Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | Solactive GBS Developed Markets Europe Large & Mid Cap |
| Investment focus | Equity, Europe |
| Fund size | CHF 190 m |
| Total expense ratio | 0.05% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Investment approach | Long-only |
| Sustainability | No |
| Fund currency | EUR |
| Currency risk | Currency unhedged |
| Volatility 1 year (in CHF) | 12.72% |
| Inception/ Listing Date | 15 January 2020 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Luxembourg |
| Fund Provider | Amundi ETF |
| Fund Structure | Company With Variable Capital (SICAV) |
| UCITS compliance | Yes |
| Administrator | CACEIS BANK Luxembourg S.A. |
| Investment Advisor | |
| Custodian Bank | CACEIS Bank Luxembourg S.A. |
| Revision Company | DELOITTE AUDIT |
| Fiscal Year End | 30 September |
| Swiss representative | CACEIS (Switzerland) SA |
| Swiss paying agent | CACEIS Bank, Montrouge, Succursale de Nyon/Suisse, Route de Signy 35, CH-1260 Nyon |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Italy | 26.0% |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | Yes |
| Securities lending counterparty |
| ASML Holding NV | 4,16% |
| Novartis AG | 2,24% |
| AstraZeneca PLC | 2,20% |
| HSBC Holdings Plc | 2,19% |
| Roche Holding AG | 2,16% |
| Shell Plc | 2,05% |
| Nestlé SA | 1,95% |
| Siemens AG | 1,42% |
| TotalEnergies SE | 1,41% |
| SAP SE | 1,36% |
| Broker | Rating | Execution fee | Account fee | |
|---|---|---|---|---|
| 0.00 CHF | 0.00 CHF | View offer* | |
| 0.00 CHF | 0.00 CHF | View offer* |
| YTD | +5.66% |
| 1 month | +2.48% |
| 3 months | +0.97% |
| 6 months | +11.77% |
| 1 year | +14.67% |
| 3 years | +36.78% |
| 5 years | +36.90% |
| Since inception (MAX) | +50.21% |
| 2025 | +18.59% |
| 2024 | +10.94% |
| 2023 | +9.27% |
| 2022 | -13.79% |
| Volatility 1 year | 12.72% |
| Volatility 3 years | 14.01% |
| Volatility 5 years | 15.85% |
| Return per risk 1 year | 1.15 |
| Return per risk 3 years | 0.78 |
| Return per risk 5 years | 0.41 |
| Maximum drawdown 1 year | -9.71% |
| Maximum drawdown 3 years | -17.95% |
| Maximum drawdown 5 years | -26.43% |
| Maximum drawdown since inception | -35.88% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | PRAE | - - | - - | - |
| XETRA | EUR | PRAE | PRAE GY IPRAE | PRA1.DE IPRAE=BNPP | BNP Paribas Arbitrage |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares Core MSCI Europe UCITS ETF EUR (Acc) | 15,224 | 0.12% p.a. | Accumulating | Sampling |
| iShares Core MSCI Europe UCITS ETF EUR (Dist) | 10,471 | 0.12% p.a. | Distributing | Sampling |
| iShares EURO STOXX 50 UCITS ETF (DE) | 9,483 | 0.09% p.a. | Distributing | Full replication |
| iShares STOXX Europe 600 UCITS ETF (DE) | 9,256 | 0.20% p.a. | Distributing | Full replication |
| Xtrackers MSCI Europe UCITS ETF 1C | 7,697 | 0.12% p.a. | Accumulating | Full replication |